NLRP3 and kidney disorder: To address NLRP3 function in human kidney disease will require the development of gene targeting strategies in low passage, primary cell cultures, specific pharmacologic therapies and ongoing characterization of biomarkers downstream of canonical and non-canonical NLRP3 pathways.